Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
3
×
archive
american society of clinical oncology (asco)
anti-inflammatory drugs
arcturus therapeutics
avrobio
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
brexanolone
camp4 therapeutics
cancer
cancer immunotherapy
clinical trials
crispr therapeutics
crispr-cas9
deals
denali therapeutics
detroit blog main
detroit top stories
eidos therapeutics
estradiol
f-star gamma
food and drug administration
gene editing
genmab
ido inhibitors
incyte
indiana blog main
indiana top stories
investing
johnson & johnson
joseph payne
larotrectinib
life sciences
loxo oncology
madrigal pharmaceuticals
medicaid
What
cancer
expanding
3
×
blood
drug
expands
fda
high
medication
pharmaceuticals
pressure
recall
risk
advised
ahead
ambien
american
announced
annual
april
asco
attendees
attention
bee
biotech
camp’s
cash
chicago
city
clinical
combinations
community’s
consumers
days
development
focus
home
impurity
key
kicks
losartan
Language
unset
Current search:
expanding
×
fda
×
@slashgear.com
4 years ago
High blood pressure drug recall expands again over cancer risk
@slashgear.com
4 years ago
Blood pressure medication recall expands over cancer risk
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
